Carl Pearl, MD
Plastic Surgery · Savannah, GANPI 1205995826
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.0% of the total across 170 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by AbbVie at 43.9% of the total. Reporting peaked in 2019 at $1,455 and has fallen 64.1% since, to $523 in 2025.
Across 170 payments — averaging $37.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Merz North America, Inc.$1K
- Galderma Laboratories, L.p.$614
- Acera Surgical, Inc.$548
- Mentor Worldwide LLC$546
- Musculoskeletal Transplant Foundation Inc.$346
- plus $299 from 7 others
What the payments were for
- Travel & lodging$3205%
- Food & beverage$6,07095%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 88 | $2,808 |
| Merz North America, Inc. | 7 | $1,229 |
| Galderma Laboratories, L.p. | 33 | $614 |
| Acera Surgical, Inc. | 5 | $548 |
| Mentor Worldwide LLC | 21 | $546 |
| Musculoskeletal Transplant Foundation Inc. | 4 | $346 |
| Zimmer Biomet | 5 | $153 |
| Sientra, Inc. | 2 | $56 |
| Baxter Healthcare | 1 | $32 |
| Smith+Nephew | 1 | $18 |
| Coopersurgical, Inc. | 1 | $17 |
| Axogen | 1 | $12 |
| Misonix Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XEOMIN$998
- ASCLERA$998
- NATRELLE SALINE-FILLED BREAST IMPLANTS$811
- Restrata Wound Matrix$495
- NATRELLE$348
- BOTOX COSMETIC$121
How this compares
$6,390 in reported general payments places this provider in the 75th percentile of 163 plastic surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 214 | $973 |
| Ondansetron OdtOndansetron | 43 | $519 |
| Doxycycline Hyclate | 69 | $373 |
| Scopolamine | 22 | $321 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 34 | $295 |
| Tramadol Hcl | 144 | $275 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 42 | $249 |
| ValacyclovirValacyclovir Hcl | 31 | $173 |
| Montelukast Sodium | 18 | $89 |
| Promethazine Hcl | 20 | $86 |
| Ondansetron Hcl | 19 | $79 |
| Methylprednisolone | 18 | $74 |
| Fluconazole | 11 | $40 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Savannah
- Anand KumarSavannah$39K
- Richard GrecoSavannah$11K
- Matthew McLeodSavannah$9K
- Luke CurtsingerSavannah$8K
- Thomas HornSavannah$5K
- David ZabelAugusta$511K
- Albert LoskenAtlanta$436K
- Jonathan NguyenAtlanta$364K
- Brian MaloneyAtlanta$224K
- Michael McNeelMarietta$160K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.